http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004034210-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 2001-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8360928fc0313f956e53e751ae1d323 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a78ec6e9064bcbdefee31f3c91ee9fe |
| publicationDate | 2004-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2004034210-A1 |
| titleOfInvention | Novel polypeptide-protein p125-77.22 and a polynucleotide encoding the same |
| abstract | The present invention discloses a novel polypeptide-protein P125-77.22 and a polynucleotide encoding the same, as well as a method of producing the polypeptide by DNA recombinant technique. The present invention also discloses methods of using the polypeptide in treatment of various diseases, such as human mucosal disease caused by BVDV infection and so on. The present invention also discloses an antagonist against the polypeptide and the therapeutic use of the same. The present invention also discloses the use of such polynucleotide encoding protein P125-77.22. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009516755-A |
| priorityDate | 2000-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 757.